Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis

Although immunotherapy has progressed in the treatment of bladder cancer, some patients still have poor prognosis. New therapeutic targets are eager to be discovered to improve the outcomes of bladder cancer. With the development of high-throughput sequencing and tumor profiling, potential tumor bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yao, Feng, Xiao-Fei, Yang, Wan-Xia, You, Chong-Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732589/
https://www.ncbi.nlm.nih.gov/pubmed/31534952
http://dx.doi.org/10.1155/2019/1093815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732589/
https://www.ncbi.nlm.nih.gov/pubmed/31534952
http://dx.doi.org/10.1155/2019/1093815

Ejemplares similares